Go Deep
Sai Parenteral's Limited
Sai Parenteral's Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,169 | 170.3 | 10.34 | 0.49 | 493.90 |
| Oct 2026 | 18,474 | 170.3 | 10.34 | 0.49 | 493.90 |
Sai Parenteral's Limited Quarterly Results
| Line Item | Jun 2026 | Sep 2025 | Jun 2025 |
|---|---|---|---|
| Revenue | 1,786,720,000.0 | 2,691,210,000.0 | 333,910,000.0 |
| Net Profit | 158,460,000.0 | -11,770,000.0 | 28,300,000.0 |
| EPS | 1.8 | — | 0.6 |
Sai Parenteral's Limited Revenue & Profit: Last 3 Years
| Line Item | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Revenue | 4,949,580,000.0 | 1,537,620,000.0 | 967,960,000.0 |
| Net Profit | 196,290,000.0 | 84,150,000.0 | 43,760,000.0 |
| EPS | 4.4 | 1.9 | 1.0 |
Sai Parenteral's Limited Balance Sheet
| Line Item | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Assets | 7,235,790,000.0 | 2,681,010,000.0 | 1,339,630,000.0 |
| Total Liabilities | 5,999,650,000.0 | 1,917,000,000.0 | 1,024,780,000.0 |
| Total Equity | 1,114,860,000.0 | 745,450,000.0 | 314,850,000.0 |
Owes vs Owns
Sai Parenteral's Limited owed ₹0.83 for every ₹1 it owned in Sep 2025, up from ₹0.76 in Mar 2023.
| Period | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.83× | 0.83× | 0.72× | 0.76× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Sai Parenteral's Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2025
Cash & short-term investments 2.1%Receivables 27.2%Inventory 20.9%Fixed assets (tangible) 23.9%Intangible assets 20.3%Other assets 5.4%
How it's funded — Mar 2025
Short-term debt 11.1%Long-term debt 17.1%Payables 26.6%Other liabilities 28.2%Shareholders' equity 17.1%
| Line Item | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Assets | |||
| Cash & short-term investments | 15.0 | 4.4 | 0.2 |
| Receivables | 196.5 | 127.1 | 61.2 |
| Inventory | 151.3 | 37.2 | 13.2 |
| Fixed assets (tangible) | 173.2 | 65.4 | 47.3 |
| Intangible assets | 146.9 | 10.0 | 0.9 |
| Long-term investments | 1.3 | 0.7 | 1.1 |
| Other assets | 39.4 | 23.3 | 10.1 |
| Liabilities & equity | |||
| Short-term debt | 80.2 | 80.1 | 42.9 |
| Long-term debt | 123.5 | 38.7 | 25.6 |
| Payables | 192.1 | 52.7 | 22.2 |
| Other liabilities | 204.2 | 20.2 | 11.7 |
| Shareholders' equity | 123.6 | 76.4 | 31.5 |
| Net tangible assets | -35.4 | 64.6 | 30.6 |
Sai Parenteral's Limited Cash Flow
| Line Item | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Operating Activities | 331,490,000.0 | -297,640,000.0 | -127,990,000.0 |
| Investing Activities | 4,350,000.0 | -463,220,000.0 | -190,290,000.0 |
| Financing Activities | -358,810,000.0 | 785,700,000.0 | 239,780,000.0 |